References
- de Belder A, Lees C, Martin J, Moncada S, Campbell S. Treatment of HELLP syndrome with nitric oxide donor. Lancet 1995; 345: 124–125
- Moake J L. Hoemolytic‐uremic syndrome. Basic science. Lancet 1994; 343: 393–397
- Neild G H. Hoemolytic‐uremic syndrome in practice. Lancet 1994; 343: 398–401
- Radomski M W, Vallance P, Whitley G, Foxwell N, Moncada S. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res 1993; 27: 1380–1382
- Raij L. Glomerular thrombosis in pregnancy. Role of the L‐arginine‐nitric oxide pathway. Kidney Int 1994; 45: 775–781
- Stuehr D J, Cho H J, Kwon N S, Weisle M F, Nathan C F. Purification and characterization of the cytokine‐induced macrophage nitric oxide synthase: An FAD‐ and FMN‐containing flavoprotein. Proc Natl Acad Sci USA 1991; 88: 7773–7777
- Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572–575
- Wennmalm Å, Benthin G, Edlund A, et al. Metabolism and excretion of nitric oxide in humans. Circ Res 1993; 73: 1121–1127
- Westberg G, Shultz P J, Raij L. Exogenous nitric oxide prevents endotoxin‐induced glomerular thrombosis in gts. Kidney Int 1994; 46: 711–716
- Åneman A, Backman V, Snygg J, von Bothmér C, Fändriks L, Pettersson A. Accumulation of an endogenous inhibitor of nitric oxide synthase during graded hemorrhagic shock. Circ Shock. 1995; 44: 111–114